News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Javelin Pharmaceuticals (JAV) Receives $2 Million Loan from Hospira, Inc. (HSP)



6/11/2010 9:26:31 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Javelin Pharmaceuticals, Inc. (NYSE -- Amex: JAV) ("Javelin") today announced that Hospira, Inc. ("Hospira") funded a $2 million loan to Javelin on June 10, 2010 under the existing loan agreement between Javelin and Hospira.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES